Answer
Yes, Zytiga (abiraterone acetate) is contraindicated in patients with severe hepatic impairment (Child-Pugh Class C).
Sources for this answer
- ZYTIGA 500 mg film-coated tabletsJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked